Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 29,237 | 37,703 | -41,261 | 40,747 | 40,533 |
| Cost of Goods | 18,213 | 23,664 | -48,321 | 27,009 | 26,194 |
| Gross Profit | 11,024 | 14,039 | 7,060 | 13,738 | 14,339 |
| Operating Expenses | 21,865 | 28,308 | -83,608 | 25,487 | 91,096 |
| Operating Income | -10,628 | -13,605 | 90,347 | -11,740 | -76,563 |
| Interest Expense | 387 | 411 | 53 | 15 | 32 |
| Other Income | 5,499 | 394 | 411 | 839 | -22 |
| Pre-tax Income | -5,516 | -13,622 | 90,705 | -10,916 | -76,617 |
| Income Tax | -2 | 92 | -299 | -599 | -3,739 |
| Net Income Continuous | -5,518 | -13,714 | 91,004 | -10,317 | -72,878 |
| Net Income Discontinuous | -4,681 | N/A | N/A | N/A | N/A |
| Net Income | $-10,199 | $-13,714 | $-49,189 | $-10,317 | $-72,878 |
| EPS Basic Total Ops | -0.23 | -0.32 | -1.15 | -0.24 | -1.72 |
| EPS Basic Continuous Ops | -0.13 | -0.32 | 2.14 | -0.24 | -1.72 |
| EPS Basic Discontinuous Ops | -0.11 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.23 | -0.32 | -1.11 | -0.24 | -1.72 |
| EPS Diluted Continuous Ops | -0.13 | -0.32 | 2.14 | -0.24 | -1.72 |
| EPS Diluted Discontinuous Ops | -0.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,173 | $-10,412 | $93,545 | $-7,430 | $-72,097 |